Results 41 to 50 of about 30,750 (313)
Candida auris, what do paediatricians need to know? [PDF]
AW is supported by the Wellcome Trust Strategic Award (grant 097377) and the MRC Centre for Medical Mycology (grant MR/N006364/1) at the University of Aberdeen.Peer reviewedPublisher ...
Warris, Adilia
core +1 more source
Increased incidence of candidemia in a tertiary care hospital with the COVID‐19 pandemic
The incidence of candidemia in our hospital has been stable over an 18‐year period (1.3 episodes per 1000 admissions). Since March 2020, we have observed an increase in cases of candidemia.
M. Nucci +5 more
semanticscholar +1 more source
Globally, candidemia displays geographical variety in terms of epidemiology and incidence. In that respect, a nationwide Greek study was conducted, reporting the epidemiology of Candida bloodstream infections and susceptibility of isolates to antifungal ...
V. Mamali +6 more
semanticscholar +1 more source
Risk factors for candidemia: a prospective matched case-control study
Background Candidemia is an opportunistic infection associated with high morbidity and mortality in patients hospitalized both inside and outside intensive care units (ICUs).
J. Poissy +69 more
semanticscholar +1 more source
Creation and assessment of a clinical predictive calculator and mortality associated with Candida krusei bloodstream infections [PDF]
Background Candida krusei bloodstream infection (CK BSI) is associated with high mortality, but whether this is due to underlying comorbidities in affected patients or the organism itself is unknown.
Hsueh, Kevin +4 more
core +2 more sources
Risk factors for candidemia: A case–control study
Background: Candida bloodstream infections (candidemia) have significant mortality and morbidity rates, as well as healthcare cost implications. Emerging multidrug-resistant Candida spp such as Candida auris, as well as increasing resistance among non ...
Serin Edwin Erayil +2 more
doaj +1 more source
Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris [PDF]
The emerging multidrug-resistant yeast pathogen Candida auris has attracted considerable attention as a source of healthcare–associated infections. We report that this highly virulent yeast has the capacity to form antifungal resistant biofilms sensitive
Borman, Andrew +6 more
core +4 more sources
Candidemia in acute leukemia patients [PDF]
Fungal infections are an important cause of morbidity and mortality in patients with acute leukemia (AL). Candidemia, once rare, is now a common nosocomial infection because of the intensity of chemotherapy, prolonged neutropenia, administration of broad-spectrum antibiotics and use of central venous catheters (CVC).
Ribeiro, P +5 more
openaire +3 more sources
Candidemia: Evolution of Drug Resistance and Novel Therapeutic Approaches
Candidemia and invasive candidiasis are the most common healthcare-associated invasive fungal infections, with a crude mortality rate of 25–50%. Candida albicans remains the most frequent etiology, followed by C. glabrata, C.
A. Tortorano +4 more
semanticscholar +1 more source
Background Although the majority of Candida infections occur in the developing world, candidemia epidemiology is poorly understood in these countries. The aim of this study was to investigate the epidemiology of non-Candida albicans (non-C.
Jinjian Fu +7 more
doaj +1 more source

